{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T01:29:00Z","timestamp":1790126940294,"version":"4.0.1"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,18]],"date-time":"2025-01-18T00:00:00Z","timestamp":1737158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,18]],"date-time":"2025-01-18T00:00:00Z","timestamp":1737158400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100018542","name":"Natural Science Foundation of Sichuan Province","doi-asserted-by":"publisher","award":["2023NSFSC0667"],"award-info":[{"award-number":["2023NSFSC0667"]}],"id":[{"id":"10.13039\/501100018542","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018542","name":"Natural Science Foundation of Sichuan Province","doi-asserted-by":"publisher","award":["2023NSFSC0667"],"award-info":[{"award-number":["2023NSFSC0667"]}],"id":[{"id":"10.13039\/501100018542","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018542","name":"Natural Science Foundation of Sichuan Province","doi-asserted-by":"publisher","award":["2023NSFSC0667"],"award-info":[{"award-number":["2023NSFSC0667"]}],"id":[{"id":"10.13039\/501100018542","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018542","name":"Natural Science Foundation of Sichuan Province","doi-asserted-by":"publisher","award":["2023NSFSC0667"],"award-info":[{"award-number":["2023NSFSC0667"]}],"id":[{"id":"10.13039\/501100018542","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018542","name":"Natural Science Foundation of Sichuan Province","doi-asserted-by":"publisher","award":["2023NSFSC0667"],"award-info":[{"award-number":["2023NSFSC0667"]}],"id":[{"id":"10.13039\/501100018542","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"DOI":"10.1007\/s00403-024-03791-7","type":"journal-article","created":{"date-parts":[[2025,1,18]],"date-time":"2025-01-18T11:19:16Z","timestamp":1737199156000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Unraveling the controversy: exploring the link between sex hormones and skin cancers through a meta-analysis and systematic review"],"prefix":"10.1007","volume":"317","author":[{"given":"Tian","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen-yu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ai","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiao","family":"Yun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-Jie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,18]]},"reference":[{"issue":"1","key":"3791_CR1","doi-asserted-by":"publisher","first-page":"62","DOI":"10.7861\/clinmedicine.16-1-62","volume":"16","author":"LL Griffin","year":"2016","unstructured":"Griffin LL, Ali FR, Lear JT (2016) Non-melanoma skin cancer. Clin Med (Lond) 16(1):62\u201365","journal-title":"Clin Med (Lond)"},{"issue":"39","key":"3791_CR2","doi-asserted-by":"publisher","first-page":"E1516","DOI":"10.1503\/cmaj.210595","volume":"193","author":"E Tang","year":"2021","unstructured":"Tang E, Fung K, Chan AW (2021) Incidence and mortality rates of keratinocyte carcinoma from 1998\u20132017: a population-based study of sex differences in Ontario, Canada. CMAJ 193(39):E1516\u2013E1524","journal-title":"CMAJ"},{"issue":"2","key":"3791_CR3","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1093\/carcin\/bgn243","volume":"30","author":"M Mancuso","year":"2009","unstructured":"Mancuso M et al (2009) Modulation of basal and squamous cell carcinoma by endogenous estrogen in mouse models of skin cancer. Carcinogenesis 30(2):340\u2013347","journal-title":"Carcinogenesis"},{"issue":"9","key":"3791_CR4","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.2105\/AJPH.2016.303349","volume":"106","author":"SN Bhupathiraju","year":"2016","unstructured":"Bhupathiraju SN et al (2016) Exogenous hormone use: oral contraceptives, Postmenopausal hormone therapy, and health outcomes in the nurses\u2019 health study. Am J Public Health 106(9):1631\u20131637","journal-title":"Am J Public Health"},{"issue":"1","key":"3791_CR5","doi-asserted-by":"publisher","first-page":"8524","DOI":"10.1038\/s41598-021-88077-y","volume":"11","author":"S Caini","year":"2021","unstructured":"Caini S et al (2021) Exogenous sex hormones, menstrual and reproductive history, and risk of non-melanoma skin cancer among women: a systematic literature review and meta-analysis. Sci Rep 11(1):8524","journal-title":"Sci Rep"},{"issue":"13","key":"3791_CR6","doi-asserted-by":"publisher","first-page":"3192","DOI":"10.3390\/cancers14133192","volume":"14","author":"M Chiavarini","year":"2022","unstructured":"Chiavarini M et al (2022) Exogenous hormone factors in relation to the risk of malignant melanoma in women: a systematic review and meta-analysis. Cancers (Basel) 14(13):3192","journal-title":"Cancers (Basel)"},{"issue":"1","key":"3791_CR7","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1186\/s12885-023-11459-0","volume":"23","author":"L Li","year":"2023","unstructured":"Li L, Pei B, Feng Y (2023) Exogenous hormone therapy and non-melanoma skin cancer (keratinocyte carcinoma) risk in women: a systematic review and meta-analysis. BMC Cancer 23(1):946","journal-title":"BMC Cancer"},{"issue":"4","key":"3791_CR8","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1111\/ajd.12282","volume":"56","author":"E Perera","year":"2015","unstructured":"Perera E et al (2015) Incidence and prevalence of non-melanoma skin cancer in Australia: a systematic review. Australas J Dermatol 56(4):258\u2013267","journal-title":"Australas J Dermatol"},{"issue":"3\u20134","key":"3791_CR9","first-page":"309","volume":"25","author":"A Pfahlberg","year":"1997","unstructured":"Pfahlberg A et al (1997) Systematic review of case-control studies: oral contraceptives show no effect on melanoma risk. Public Health Rev 25(3\u20134):309\u2013315","journal-title":"Public Health Rev"},{"issue":"1","key":"3791_CR10","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/bjc.1981.145","volume":"44","author":"SA Adam","year":"1981","unstructured":"Adam SA et al (1981) A case-control study of the possible association between oral contraceptives and malignant melanoma. Br J Cancer 44(1):45\u201350. https:\/\/doi.org\/10.1038\/bjc.1981.145","journal-title":"Br J Cancer"},{"issue":"3","key":"3791_CR11","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1093\/ije\/19.3.522","volume":"19","author":"R Zanetti","year":"1990","unstructured":"Zanetti R et al (1990) Cutaneous malignant melanoma in females: the role of hormonal and reproductive factors. Int J Epidemiol 19(3):522\u2013526. https:\/\/doi.org\/10.1093\/ije\/19.3.522","journal-title":"Int J Epidemiol"},{"issue":"7","key":"3791_CR12","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.annepidem.2004.10.005","volume":"15","author":"L Naldi","year":"2005","unstructured":"Naldi L et al (2005) Cutaneous malignant melanoma in women. Phenotypic characteristics, sun exposure, and hormonal factors: a case-control study from Italy. Ann Epidemiol 15(7):545\u2013550. https:\/\/doi.org\/10.1016\/j.annepidem.2004.10.005","journal-title":"Ann Epidemiol"},{"issue":"5","key":"3791_CR13","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/bjc.1984.235","volume":"50","author":"CD Holman","year":"1984","unstructured":"Holman CD, Armstrong BK, Heenan PJ (1984) Cutaneous malignant melanoma in women: exogenous sex hormones and reproductive factors. Br J Cancer 50(5):673\u2013680. https:\/\/doi.org\/10.1038\/bjc.1984.235","journal-title":"Br J Cancer"},{"issue":"10","key":"3791_CR14","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1093\/oxfordjournals.aje.a117361","volume":"141","author":"EA Holly","year":"1995","unstructured":"Holly EA, Cress RD, Ahn DK (1995) Cutaneous melanoma in women. III. Reproductive factors and oral contraceptive use. Am J Epidemiol 141(10):943\u2013950. https:\/\/doi.org\/10.1093\/oxfordjournals.aje.a117361","journal-title":"Am J Epidemiol"},{"issue":"2","key":"3791_CR15","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s10552-011-9887-4","volume":"23","author":"F Birch-Johansen","year":"2012","unstructured":"Birch-Johansen F et al (2012) Does hormone replacement therapy and use of oral contraceptives increase the risk of non-melanoma skin cancer? Cancer Causes Control 23(2):379\u2013388. https:\/\/doi.org\/10.1007\/s10552-011-9887-4","journal-title":"Cancer Causes Control"},{"issue":"2","key":"3791_CR16","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1093\/annonc\/mdn589","volume":"20","author":"ER Koomen","year":"2009","unstructured":"Koomen ER et al (2009) Estrogens, oral contraceptives and hormonal replacement therapy increase the incidence of cutaneous melanoma: a population-based case-control study. Ann Oncol 20(2):358\u2013364. https:\/\/doi.org\/10.1093\/annonc\/mdn589","journal-title":"Ann Oncol"},{"issue":"12","key":"3791_CR17","doi-asserted-by":"publisher","first-page":"3267","DOI":"10.1002\/ijc.32674","volume":"146","author":"I Cervenka","year":"2020","unstructured":"Cervenka I et al (2020) Exogenous hormone use and cutaneous melanoma risk in women: the European prospective investigation into cancer and nutrition. Int J Cancer 146(12):3267\u20133280. https:\/\/doi.org\/10.1002\/ijc.32674","journal-title":"Int J Cancer"},{"issue":"34","key":"3791_CR18","doi-asserted-by":"publisher","first-page":"4058","DOI":"10.1200\/jco.2015.62.0625","volume":"33","author":"EK Cahoon","year":"2015","unstructured":"Cahoon EK et al (2015) Female estrogen-related factors and incidence of basal cell carcinoma in a nationwide US cohort. J Clin Oncol 33(34):4058\u20134065. https:\/\/doi.org\/10.1200\/jco.2015.62.0625","journal-title":"J Clin Oncol"},{"issue":"2","key":"3791_CR19","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.canlet.2011.07.007","volume":"310","author":"SM Langevin","year":"2011","unstructured":"Langevin SM, Grandis JR, Taioli E (2011) Female hormonal and reproductive factors and head and neck squamous cell carcinoma risk. Cancer Lett 310(2):216\u2013221. https:\/\/doi.org\/10.1016\/j.canlet.2011.07.007","journal-title":"Cancer Lett"},{"issue":"3","key":"3791_CR20","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.jaad.2017.09.033","volume":"78","author":"CM Olsen","year":"2018","unstructured":"Olsen CM et al (2018) Hormonal and reproductive factors and incidence of basal cell carcinoma and squamous cell carcinoma in a large, prospective cohort. J Am Acad Dermatol 78(3):615-618e2. https:\/\/doi.org\/10.1016\/j.jaad.2017.09.033","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"3791_CR21","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1093\/ije\/27.5.751","volume":"27","author":"MA Smith","year":"1998","unstructured":"Smith MA et al (1998) Hormonal and reproductive influences and risk of melanoma in women. Int J Epidemiol 27(5):751\u2013757. https:\/\/doi.org\/10.1093\/ije\/27.5.751","journal-title":"Int J Epidemiol"},{"issue":"9","key":"3791_CR22","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1002\/ijc.30878","volume":"141","author":"E Botteri","year":"2017","unstructured":"Botteri E et al (2017) Menopausal hormone therapy and risk of melanoma: do estrogens and progestins have a different role? Int J Cancer 141(9):1763\u20131770. https:\/\/doi.org\/10.1002\/ijc.30878","journal-title":"Int J Cancer"},{"issue":"10","key":"3791_CR23","doi-asserted-by":"publisher","first-page":"2390","DOI":"10.1002\/ijc.31644","volume":"143","author":"I Cervenka","year":"2018","unstructured":"Cervenka I et al (2018) Oral contraceptive use and cutaneous melanoma risk: a French prospective cohort study. Int J Cancer 143(10):2390\u20132399. https:\/\/doi.org\/10.1002\/ijc.31644","journal-title":"Int J Cancer"},{"issue":"5","key":"3791_CR24","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1038\/bjc.1984.236","volume":"50","author":"V Beral","year":"1984","unstructured":"Beral V et al (1984) Oral contraceptive use and malignant melanoma in Australia. Br J Cancer 50(5):681\u2013685. https:\/\/doi.org\/10.1038\/bjc.1984.236","journal-title":"Br J Cancer"},{"issue":"6","key":"3791_CR25","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1007\/bf00052752","volume":"3","author":"JR Palmer","year":"1992","unstructured":"Palmer JR et al (1992) Oral contraceptive use and risk of cutaneous malignant melanoma. Cancer Causes Control 3(6):547\u2013554. https:\/\/doi.org\/10.1007\/bf00052752","journal-title":"Cancer Causes Control"},{"issue":"3","key":"3791_CR26","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/bf00124252","volume":"3","author":"MG L\u00ea","year":"1992","unstructured":"L\u00ea MG et al (1992) Oral contraceptive use and risk of cutaneous malignant melanoma in a case-control study of French women. Cancer Causes Control 3(3):199\u2013205. https:\/\/doi.org\/10.1007\/bf00124252","journal-title":"Cancer Causes Control"},{"issue":"5","key":"3791_CR27","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1038\/sj.bjc.6690787","volume":"81","author":"D Feskanich","year":"1999","unstructured":"Feskanich D et al (1999) Oral contraceptive use and risk of melanoma in premenopausal women. Br J Cancer 81(5):918\u2013923. https:\/\/doi.org\/10.1038\/sj.bjc.6690787","journal-title":"Br J Cancer"},{"issue":"12","key":"3791_CR28","doi-asserted-by":"publisher","first-page":"2760","DOI":"10.1038\/jid.2009.168","volume":"129","author":"KM Applebaum","year":"2009","unstructured":"Applebaum KM et al (2009) Oral contraceptives: a risk factor for squamous cell carcinoma? J Invest Dermatol 129(12):2760\u20132765. https:\/\/doi.org\/10.1038\/jid.2009.168","journal-title":"J Invest Dermatol"},{"issue":"7","key":"3791_CR29","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1002\/ijc.32150","volume":"145","author":"I Cervenka","year":"2019","unstructured":"Cervenka I et al (2019) Postmenopausal hormone use and cutaneous melanoma risk: a French prospective cohort study. Int J Cancer 145(7):1754\u20131767. https:\/\/doi.org\/10.1002\/ijc.32150","journal-title":"Int J Cancer"},{"issue":"2","key":"3791_CR30","doi-asserted-by":"publisher","first-page":"427","DOI":"10.3390\/ijerph7020427","volume":"7","author":"MM Asgari","year":"2010","unstructured":"Asgari MM et al (2010) Potential risk factors for cutaneous squamous cell carcinoma include oral contraceptives: results of a nested case-control study. Int J Environ Res Public Health 7(2):427\u2013442. https:\/\/doi.org\/10.3390\/ijerph7020427","journal-title":"Int J Environ Res Public Health"},{"issue":"7","key":"3791_CR31","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1038\/s41416-019-0411-z","volume":"120","author":"GM Donley","year":"2019","unstructured":"Donley GM et al (2019) Reproductive factors, exogenous hormone use and incidence of melanoma among women in the United States. Br J Cancer 120(7):754\u2013760. https:\/\/doi.org\/10.1038\/s41416-019-0411-z","journal-title":"Br J Cancer"},{"issue":"5","key":"3791_CR32","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1093\/humrep\/deac029","volume":"37","author":"JZ Mai","year":"2022","unstructured":"Mai JZ et al (2022) Reproductive factors, hormone use, and incidence of melanoma in a cohort of US radiologic technologists. Hum Reprod 37(5):1059\u20131068. https:\/\/doi.org\/10.1093\/humrep\/deac029","journal-title":"Hum Reprod"},{"issue":"5","key":"3791_CR33","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1093\/aje\/kwk040","volume":"165","author":"CS Lea","year":"2007","unstructured":"Lea CS et al (2007) Reproductive risk factors for cutaneous melanoma in women: a case-control study. Am J Epidemiol 165(5):505\u2013513. https:\/\/doi.org\/10.1093\/aje\/kwk040","journal-title":"Am J Epidemiol"},{"issue":"9","key":"3791_CR34","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1038\/bjc.1996.216","volume":"73","author":"J Westerdahl","year":"1996","unstructured":"Westerdahl J et al (1996) Risk of malignant melanoma in relation to drug intake, alcohol, smoking and hormonal factors. Br J Cancer 73(9):1126\u20131131. https:\/\/doi.org\/10.1038\/bjc.1996.216","journal-title":"Br J Cancer"},{"issue":"2","key":"3791_CR35","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1159\/000360137","volume":"82","author":"E Benyi","year":"2014","unstructured":"Benyi E et al (2014) Risks of malignant and non-malignant tumours in tall women treated with high-dose oestrogen during adolescence. Horm Res Paediatr 82(2):89\u201396. https:\/\/doi.org\/10.1159\/000360137","journal-title":"Horm Res Paediatr"},{"issue":"1","key":"3791_CR36","doi-asserted-by":"publisher","first-page":"10572","DOI":"10.1038\/s41598-023-37687-9","volume":"13","author":"JS Yuk","year":"2023","unstructured":"Yuk JS et al (2023) Skin cancer risk of menopausal hormone therapy in a Korean cohort. Sci Rep 13(1):10572. https:\/\/doi.org\/10.1038\/s41598-023-37687-9","journal-title":"Sci Rep"},{"issue":"4","key":"3791_CR37","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1046\/j.1365-2133.2000.03782.x","volume":"143","author":"MP Vessey","year":"2000","unstructured":"Vessey MP, Painter R, Powell J (2000) Skin disorders in relation to oral contraception and other factors, including age, social class, smoking and body mass index. findings in a large cohort study. Br J Dermatol 143(4):815\u2013820. https:\/\/doi.org\/10.1046\/j.1365-2133.2000.03782.x","journal-title":"Br J Dermatol"},{"issue":"4","key":"3791_CR38","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1016\/j.fertnstert.2015.06.045","volume":"104","author":"LA Brinton","year":"2015","unstructured":"Brinton LA et al (2015) Effects of fertility drugs on cancers other than breast and gynecologic malignancies. Fertil Steril 104(4):980\u2013988. https:\/\/doi.org\/10.1016\/j.fertnstert.2015.06.045","journal-title":"Fertil Steril"},{"issue":"4","key":"3791_CR39","first-page":"537","volume":"68","author":"C Bain","year":"1982","unstructured":"Bain C et al (1982) Oral contraceptive use and malignant melanoma. J Natl Cancer Inst 68(4):537\u2013539","journal-title":"J Natl Cancer Inst"},{"issue":"10","key":"3791_CR40","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1007\/s10552-010-9591-9","volume":"21","author":"T Behrens","year":"2010","unstructured":"Behrens T et al (2010) Hormonal exposures and the risk of uveal melanoma. Cancer Causes Control 21(10):1625\u20131634. https:\/\/doi.org\/10.1007\/s10552-010-9591-9","journal-title":"Cancer Causes Control"},{"issue":"9","key":"3791_CR41","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1023\/b:caco.0000003839.56954.73","volume":"14","author":"DM Freedman","year":"2003","unstructured":"Freedman DM et al (2003) Risk of melanoma in relation to smoking, alcohol intake, and other factors in a large occupational cohort. Cancer Causes Control 14(9):847\u2013857. https:\/\/doi.org\/10.1023\/b:caco.0000003839.56954.73","journal-title":"Cancer Causes Control"},{"issue":"6","key":"3791_CR42","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/0010-7824(91)90008-4","volume":"43","author":"A Green","year":"1991","unstructured":"Green A (1991) Oral contraceptives and skin neoplasia. Contraception 43(6):653\u2013666. https:\/\/doi.org\/10.1016\/0010-7824(91)90008-4","journal-title":"Contraception"},{"issue":"3","key":"3791_CR43","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/bjc.1991.99","volume":"63","author":"PC Hannaford","year":"1991","unstructured":"Hannaford PC et al (1991) Oral contraceptives and malignant melanoma. Br J Cancer 63(3):430\u2013433","journal-title":"Br J Cancer"},{"issue":"3","key":"3791_CR44","first-page":"617","volume":"72","author":"SP Helmrich","year":"1984","unstructured":"Helmrich SP et al (1984) Lack of an elevated risk of malignant melanoma in relation to oral contraceptive use. J Natl Cancer Inst 72(3):617\u2013620","journal-title":"J Natl Cancer Inst"},{"issue":"12","key":"3791_CR45","doi-asserted-by":"publisher","first-page":"2418","DOI":"10.1093\/humrep\/dez222","volume":"34","author":"BM Hicks","year":"2019","unstructured":"Hicks BM et al (2019) Hormone replacement therapy and the risk of melanoma in post-menopausal women. Hum Reprod 34(12):2418\u20132429. https:\/\/doi.org\/10.1093\/humrep\/dez222","journal-title":"Hum Reprod"},{"key":"3791_CR46","doi-asserted-by":"publisher","first-page":"k3609","DOI":"10.1136\/bmj.k3609","volume":"362","author":"L Iversen","year":"2018","unstructured":"Iversen L et al (2018) Association between contemporary hormonal contraception and ovarian cancer in women of reproductive age in Denmark: prospective, nationwide cohort study. BMJ 362:k3609","journal-title":"BMJ"},{"issue":"2","key":"3791_CR47","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1002\/ijc.30072","volume":"139","author":"LF Kuklinski","year":"2016","unstructured":"Kuklinski LF et al (2016) Sex hormones and the risk of keratinocyte cancers among women in the United States: a population-based case-control study. Int J Cancer 139(2):300\u2013309. https:\/\/doi.org\/10.1002\/ijc.30072","journal-title":"Int J Cancer"},{"issue":"1","key":"3791_CR48","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1046\/j.1365-2133.2003.05352.x","volume":"149","author":"T Milan","year":"2003","unstructured":"Milan T et al (2003) Lifestyle differences in twin pairs discordant for basal cell carcinoma of the skin. Br J Dermatol 149(1):115\u2013123. https:\/\/doi.org\/10.1046\/j.1365-2133.2003.05352.x","journal-title":"Br J Dermatol"},{"issue":"6","key":"3791_CR49","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1002\/ijc.2910420603","volume":"42","author":"A Osterlind","year":"1988","unstructured":"Osterlind A et al (1988) The danish case-control study of cutaneous malignant melanoma. III. hormonal and reproductive factors in women. Int J Cancer 42(6):821\u2013824. https:\/\/doi.org\/10.1002\/ijc.2910420603","journal-title":"Int J Cancer"},{"issue":"6","key":"3791_CR50","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1111\/bjd.20640","volume":"185","author":"NC Stoer","year":"2021","unstructured":"Stoer NC et al (2021) Menopausal hormone therapy and risk of melanoma: a population-based cohort study. Br J Dermatol 185(6):1266\u20131267. https:\/\/doi.org\/10.1111\/bjd.20640","journal-title":"Br J Dermatol"},{"issue":"5","key":"3791_CR51","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1097\/00008390-200110000-00015","volume":"11","author":"P Young","year":"2001","unstructured":"Young P et al (2001) A study of infertility treatment and melanoma. Melanoma Res 11(5):535\u2013541. https:\/\/doi.org\/10.1097\/00008390-200110000-00015","journal-title":"Melanoma Res"},{"issue":"3","key":"3791_CR52","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.det.2014.03.014","volume":"32","author":"RS Dawe","year":"2014","unstructured":"Dawe RS, Ibbotson SH (2014) Drug-induced photosensitivity. Dermatol Clin 32(3):363\u2013368","journal-title":"Dermatol Clin"},{"issue":"5","key":"3791_CR53","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1210\/er.2007-0001","volume":"28","author":"RH Straub","year":"2007","unstructured":"Straub RH (2007) The complex role of estrogens in inflammation. Endocr Rev 28(5):521\u2013574","journal-title":"Endocr Rev"},{"key":"3791_CR54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-1-4939-3127-9_1","volume":"1366","author":"KM Eyster","year":"2016","unstructured":"Eyster KM (2016) The estrogen receptors: an overview from different perspectives. Methods Mol Biol 1366:1\u201310","journal-title":"Methods Mol Biol"},{"issue":"2","key":"3791_CR55","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1046\/j.1523-1747.2001.01422.x","volume":"117","author":"N Kanda","year":"2001","unstructured":"Kanda N, Watanabe S (2001) 17beta-estradiol, progesterone, and dihydrotestosterone suppress the growth of human melanoma by inhibiting interleukin-8 production. J Invest Dermatol 117(2):274\u2013283","journal-title":"J Invest Dermatol"},{"issue":"1","key":"3791_CR56","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1097\/DAD.0b013e3182914c64","volume":"36","author":"JH Zhou","year":"2014","unstructured":"Zhou JH et al (2014) Immunohistochemical expression of hormone receptors in melanoma of pregnant women, nonpregnant women, and men. Am J Dermatopathol 36(1):74\u201379","journal-title":"Am J Dermatopathol"},{"issue":"10","key":"3791_CR57","doi-asserted-by":"publisher","first-page":"2702","DOI":"10.1158\/1078-0432.CCR-09-1753","volume":"16","author":"I Barone","year":"2010","unstructured":"Barone I, Brusco L, Fuqua SA (2010) Estrogen receptor mutations and changes in downstream gene expression and signaling. Clin Cancer Res 16(10):2702\u20132708","journal-title":"Clin Cancer Res"},{"issue":"1","key":"3791_CR58","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1677\/jme.0.0240145","volume":"24","author":"AH Taylor","year":"2000","unstructured":"Taylor AH, Al-Azzawi F (2000) Immunolocalisation of oestrogen receptor beta in human tissues. J Mol Endocrinol 24(1):145\u2013155","journal-title":"J Mol Endocrinol"},{"issue":"11","key":"3791_CR59","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1016\/j.steroids.2008.04.006","volume":"73","author":"EM Fox","year":"2008","unstructured":"Fox EM, Davis RJ, Shupnik MA (2008) ERbeta in breast cancer\u2013onlooker, passive player, or active protector? Steroids 73(11):1039\u20131051","journal-title":"Steroids"},{"key":"3791_CR60","doi-asserted-by":"publisher","first-page":"140","DOI":"10.3389\/fendo.2016.00140","volume":"7","author":"M Marzagalli","year":"2016","unstructured":"Marzagalli M et al (2016) Estrogen receptor beta in melanoma: from molecular insights to potential clinical utility. Front Endocrinol (Lausanne) 7:140","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"3791_CR61","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1001\/archdermatol.2008.537","volume":"145","author":"V de Giorgi","year":"2009","unstructured":"de Giorgi V et al (2009) Estrogen receptor expression in cutaneous melanoma: a real-time reverse transcriptase-polymerase chain reaction and immunohistochemical study. Arch Dermatol 145(1):30\u201336","journal-title":"Arch Dermatol"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-024-03791-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00403-024-03791-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-024-03791-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,18]],"date-time":"2025-01-18T11:19:19Z","timestamp":1737199159000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00403-024-03791-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,18]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3791"],"URL":"https:\/\/doi.org\/10.1007\/s00403-024-03791-7","relation":{},"ISSN":["1432-069X"],"issn-type":[{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,18]]},"assertion":[{"value":"25 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 December 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"292"}}